AstraZeneca pulls EU filing for antibody as CHMP backs Gazyvaro in lupus

AstraZeneca has withdrawn its European marketing application for a monoclonal antibody in a subset of amyloidosis patients. The candidate had previously failed two late-stage studies in a broader population, but the drugmaker then said that ...